Landscapes / Targets
CYP11B2
3 drugs act on CYP11B2, in 12 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cortisol synthesis inhibitor |
Recordati +1 · Public NVS |
Approved | 21 Jul 2027Phase 2 trial completes | ||
| Next date | 21 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Cushing Syndrome, Hypertension and 1 more | ||||
| Open drug page | |||||
— |
Boehringer Ingelheim · Private |
Phase 3 | 31 Dec 2026Phase 3 trial completes | ||
| Next date | 31 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Heart Failure, Kidney Disease, Chronic and 3 more | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Uncontrolled Hypertension, Hypertension (HTN) and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026